SHPMY Stock - Shanghai Pharmaceuticals Holding Co., Ltd
Unlock GoAI Insights for SHPMY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $275.25B | $260.30B | $231.98B | $215.82B | $191.91B |
| Gross Profit | $30.63B | $31.33B | $30.49B | $28.54B | $27.44B |
| Gross Margin | 11.1% | 12.0% | 13.1% | 13.2% | 14.3% |
| Operating Income | $8.14B | $7.67B | $9.01B | $8.21B | $7.18B |
| Net Income | $4.55B | $3.77B | $5.62B | $5.09B | $4.50B |
| Net Margin | 1.7% | 1.4% | 2.4% | 2.4% | 2.3% |
| EPS | $6.15 | $5.10 | $8.05 | $8.95 | $7.90 |
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Visit WebsiteEarnings History & Surprises
SHPMYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q4 2025 | Oct 27, 2025 | — | $0.02 | — | — |
Q3 2025 | Aug 25, 2025 | — | $0.59 | — | — |
Q2 2025 | Apr 28, 2025 | — | $0.25 | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.09 | — | — |
Q4 2024 | Oct 29, 2024 | — | $0.21 | — | — |
Q3 2024 | Aug 26, 2024 | — | $0.26 | — | — |
Q2 2024 | Apr 26, 2024 | — | $0.29 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.22 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.20 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.30 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.16 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.28 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.64 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.35 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.17 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.25 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.40 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.57 | — | — |
Latest News
Frequently Asked Questions about SHPMY
What is SHPMY's current stock price?
What is the analyst price target for SHPMY?
What sector is Shanghai Pharmaceuticals Holding Co., Ltd in?
What is SHPMY's market cap?
Does SHPMY pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SHPMY for comparison